The emerging approach of the medication represents a exciting development in the care of type 2 diabetes. Unlike existing medications, tirzepatide impacts multiple pathways – glucagon-like peptide-1 (GLP-1) and the GIP hormone – resulting in improved glucose control and anticipated reduction in weight. Scientists are studying its future benefit… Read More